wingless-type MMTV integration site family member 10B: a potential drug target and biomarker
wingless-type MMTV integration site family member 10B: a potential drug target and biomarker
Introduction
The wingless-type MMTV integration site family member 10B (WNT10B) is a non-coding RNA molecule that plays a crucial role in the development and maintenance of tissues, including blood vessels and epithelial organs. WNT10B has been shown to be involved in various physiological processes, including cell growth, differentiation and regulation, and has also been implicated in several diseases, including cancer. As a potential drug target and biomarker, the study of WNT10B is of great interest to researchers.
During the past decade, the wingless-type MMTV integration site family has been extensively studied, and several studies have identified its involvement in various biological processes. One of the most significant findings is the role of WNT10B in cancer progression. Several studies have shown that High levels of WNT10B expression are associated with poor prognosis in various cancers, including breast, ovarian, and colorectal cancers. Additionally, researchers have also found that inhibiting WNT10B can be an effective way to treat cancer.
Another promising application of WNT10B is its potential as a biomarker. The wingless-type MMTV integration site family has been shown to be involved in various physiological processes, including cell growth, differentiation and regulation. By studying the levels of WNT10B in various tissues and fluids , researchers can gain insights into the health status of an individual and monitor the effectiveness of various treatments.
WNT10B and cancer
WNT10B has been shown to be involved in the development and progression of several types of cancer. For example, studies have shown that high levels of WNT10B expression are associated with poor prognosis in breast cancer. Researchers have also found that inhibiting WNT10B can be an effective way to treat breast cancer by suppressing its role in cell growth and division.
In addition to its involvement in breast cancer, WNT10B has also been shown to be involved in the development and progression of other types of cancer, including ovarian and colorectal cancers. These studies highlight the potential of WNT10B as a drug target for cancer treatment.
WNT10B and cell growth and division
WNT10B plays a crucial role in the regulation of cell growth and division. Studies have shown that WNT10B acts as a negative regulator of the T-cell receptor (TCR), which is a critical signaling pathway that regulates the growth and survival of T-cells.
Additionally, WNT10B has also been shown to play a role in the regulation of cell cycle progression. Researchers have found that high levels of WNT10B expression are associated with longer cell cycles and a higher risk of cell proliferation.
WNT10B and stem cells
WNT10B has also been shown to be involved in the regulation of stem cell properties. Studies have shown that WNT10B can induce stem cells to differentiate into functional tissues, such as blood vessels and epithelial organs.
In addition, WNT10B has also been shown to play a role in the regulation of the Notch signaling pathway. Notch signaling is a critical pathway that regulates stem cell properties and has been implicated in various diseases, including cancer.
WNT10B and inflammation
WNT10B has also been shown to be involved in the regulation of inflammation. Studies have shown that high levels of WNT10B expression are associated with increased inflammation and an increased risk of various diseases, including cancer.
In conclusion, the wingless-type MMTV integration site family member 10B (WNT10B) has been shown to be involved in various physiological processes, including cell growth, differentiation and regulation, and has also been implicated in several diseases, including cancer. As a potential drug target and biomarker, the study of WNT10B is of great interest to researchers.
Protein Name: Wnt Family Member 10B
Functions: Member of the Wnt ligand gene family that encodes for secreted proteins, which activate the Wnt signaling cascade. Specifically activates canonical Wnt/beta-catenin signaling and thus triggers beta-catenin/LEF/TCF-mediated transcriptional programs. Involved in signaling networks controlling stemness, pluripotency and cell fate decisions. Acts in the immune system, mammary gland, adipose tissue, bone and skin
The "WNT10B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about WNT10B comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
WNT11 | WNT16 | WNT2 | WNT2B | WNT3 | WNT3A | WNT4 | WNT5A | WNT5B | WNT6 | WNT7A | WNT7B | WNT8A | WNT8B | WNT9A | WNT9B | WRAP53 | WRAP73 | WRN | WRNIP1 | WSB1 | WSB2 | WSCD1 | WSCD2 | WSPAR | WT1 | WT1-AS | WTAP | WTAPP1 | WTIP | WWC1 | WWC2 | WWC2-AS2 | WWC3 | WWOX | WWP1 | WWP2 | WWTR1 | WWTR1-AS1 | XAB2 | XACT | XAF1 | XAGE-4 | XAGE1A | XAGE1B | XAGE1D | XAGE2 | XAGE3 | XAGE5 | XBP1 | XCL1 | XCL2 | XCR1 | XDH | XG | XGY2 | XIAP | XIRP1 | XIRP2 | XIST | XK | XKR3 | XKR4 | XKR5 | XKR6 | XKR7 | XKR8 | XKR9 | XKRX | XKRY | XKRYP7 | XLOC_007697 | XLOC_008559 | XLOC_009911 | XNDC1N | XPA | XPC | XPC complex | XPNPEP1 | XPNPEP2 | XPNPEP3 | XPO1 | XPO4 | XPO5 | XPO6 | XPO7 | XPOT | XPR1 | XRCC1 | XRCC2 | XRCC3 | XRCC4 | XRCC5 | XRCC6 | XRCC6P5 | XRN1 | XRN2 | XRRA1 | XXYLT1 | XXYLT1-AS2
